Seres Therapeutics, Inc. (MCRB)
Market Closed
1 Sep, 20:00
$
5. 18
+0.27
+5.499%
After Hours
$
+0.12 +2.3166% 5. 30
45.13M Market Cap
- P/E Ratio
- Div Yield
49,166 Volume
-0.99 Eps
$ 4.91
Previous Close 
Analysts:
Want to track MCRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seres Therapeutics, Inc. (MCRB) Statistics
Valuation metrics
Market Cap 45.13M
Enterprise value 90.53M
Trailing P/E (ttm) -2.11
Forward P/E -0.93
PEG ratio 0
Price/Sales (ttm) 26.28
Price/Book (mrq) 1.43
Enterprise Value/Revenue 48.08
Enterprise Value/EBITDA -2.04
Overview
Shares outstanding 9.56M
Float 7.28M
Shares short 597.31K
% Held by insiders 0.12%
% Held by institutions 0.26%
Average volume (10 days) 32.49K
Average volume (90 days) 75.06K
Price summary
52-Week low 4.32
52-Week high 29.98
Beta 0.26
50-Day moving average 5.28
200-Day moving average 8.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 22 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -11.93%
Operating margin -44.63%
Operational effectiveness
Return on assets -0.22%
Return on equity -0.6%
Income Statement
Revenue (ttm) 789K
Revenue per share (ttm) 0.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -54.81M
EBITDA -89.84M
Net income to common (ttm) 5.7M
Diluted EPS (ttm) -2.33
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 45.77M
Total cash per share (mrq) 1.62
Total debt (mrq) 82.97M
Total Debt/Equity (mrq) 1.64
Current ratio (mrq) 2.11%
Book value per share (mrq) 3.58
Cash Flow
Cash flow statement 1.12M
Levered free cash flow (LFCF) -54.96M
